LEUKEMIA, ACUTE LYMPHOBLASTIC
Clinical trials for LEUKEMIA, ACUTE LYMPHOBLASTIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, ACUTE LYMPHOBLASTIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, ACUTE LYMPHOBLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on leukemia shows promise in early trial
Disease control OngoingThis Phase 2 trial tests whether adding the targeted drug ponatinib to standard chemotherapy can improve outcomes for adults with a specific, high-risk type of acute lymphoblastic leukemia called BCR/ABL1-like ALL. The study enrolls 32 patients aged 18-65 who have not yet been tr…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for leukemia patients allergic to key chemo drug
Disease control NO_LONGER_AVAILABLEThis study offers Erwinase, a different form of chemotherapy, to children and adults with acute lymphoblastic leukemia (ALL) who have had allergic reactions to standard L-asparaginase drugs. The goal is to provide a safe treatment option for those who cannot use the usual medicat…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC